Bruker PE Ratio 2012-2026 | BRKR
Current and historical p/e ratio for Bruker (BRKR) from 2012 to 2026. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Bruker PE ratio as of June 11, 2026 is 20.54.
| Bruker PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-06-12 | 54.23 | 0.00 | |
| 2026-03-31 | 36.12 | $-0.24 | 0.00 |
| 2025-12-31 | 47.04 | $-0.15 | 0.00 |
| 2025-09-30 | 32.41 | $-0.16 | 0.00 |
| 2025-06-30 | 41.03 | $0.52 | 78.91 |
| 2025-03-31 | 41.52 | $0.52 | 79.84 |
| 2024-12-31 | 58.24 | $0.76 | 76.63 |
| 2024-09-30 | 68.56 | $2.06 | 33.28 |
| 2024-06-30 | 63.30 | $2.39 | 26.48 |
| 2024-03-31 | 93.11 | $2.73 | 34.11 |
| 2023-12-31 | 72.79 | $2.90 | 25.10 |
| 2023-09-30 | 61.67 | $2.17 | 28.42 |
| 2023-06-30 | 73.12 | $2.16 | 33.85 |
| 2023-03-31 | 77.93 | $2.10 | 37.11 |
| 2022-12-31 | 67.51 | $1.99 | 33.92 |
| 2022-09-30 | 52.37 | $1.82 | 28.77 |
| 2022-06-30 | 61.89 | $1.80 | 34.38 |
| 2022-03-31 | 63.35 | $1.85 | 34.25 |
| 2021-12-31 | 82.62 | $1.81 | 45.65 |
| 2021-09-30 | 76.86 | $1.76 | 43.67 |
| 2021-06-30 | 74.74 | $1.54 | 48.53 |
| 2021-03-31 | 63.20 | $1.32 | 47.88 |
| 2020-12-31 | 53.18 | $1.02 | 52.14 |
| 2020-09-30 | 39.02 | $1.02 | 38.26 |
| 2020-06-30 | 39.90 | $1.06 | 37.64 |
| 2020-03-31 | 35.14 | $1.13 | 31.10 |
| 2019-12-31 | 49.90 | $1.26 | 39.60 |
| 2019-09-30 | 42.97 | $1.31 | 32.80 |
| 2019-06-30 | 48.82 | $1.20 | 40.68 |
| 2019-03-31 | 37.53 | $1.17 | 32.08 |
| 2018-12-31 | 29.04 | $1.14 | 25.47 |
| 2018-09-30 | 32.59 | $0.63 | 51.73 |
| 2018-06-30 | 28.26 | $0.58 | 48.72 |
| 2018-03-31 | 29.08 | $0.53 | 54.86 |
| 2017-12-31 | 33.31 | $0.49 | 67.98 |
| 2017-09-30 | 28.84 | $0.94 | 30.68 |
| 2017-06-30 | 27.92 | $1.00 | 27.92 |
| 2017-03-31 | 22.55 | $0.94 | 23.99 |
| 2016-12-31 | 20.44 | $0.95 | 21.52 |
| 2016-09-30 | 21.82 | $0.88 | 24.80 |
| 2016-06-30 | 21.87 | $0.66 | 33.13 |
| 2016-03-31 | 26.89 | $0.70 | 38.41 |
| 2015-12-31 | 23.27 | $0.60 | 38.78 |
| 2015-09-30 | 15.75 | $0.39 | 40.39 |
| 2015-06-30 | 19.57 | $0.35 | 55.91 |
| 2015-03-31 | 17.71 | $0.32 | 55.34 |
| 2014-12-31 | 18.81 | $0.33 | 57.00 |
| 2014-09-30 | 17.76 | $0.39 | 45.53 |
| 2014-06-30 | 23.27 | $0.46 | 50.59 |
| 2014-03-31 | 21.85 | $0.50 | 43.70 |
| 2013-12-31 | 18.95 | $0.48 | 39.49 |
| 2013-09-30 | 19.80 | $0.34 | 58.23 |
| 2013-06-30 | 15.48 | $0.48 | 32.26 |
| 2013-03-31 | 18.31 | $0.40 | 45.78 |
| 2012-12-31 | 14.61 | $0.46 | 31.76 |
| 2012-09-30 | 12.55 | $0.62 | 20.24 |
| 2012-06-30 | 12.76 | $0.50 | 25.52 |
| 2012-03-31 | 14.68 | $0.57 | 25.75 |
| 2011-12-31 | 11.91 | $0.55 | 21.65 |
| 2011-09-30 | 12.97 | $0.49 | 26.47 |
| 2011-06-30 | 19.52 | $0.54 | 36.15 |
| 2011-03-31 | 19.99 | $0.55 | 36.35 |
| 2010-12-31 | 15.92 | $0.58 | 27.44 |
| 2010-09-30 | 13.45 | $0.67 | 20.08 |
| 2010-06-30 | 11.66 | $0.60 | 19.43 |
| 2010-03-31 | 14.05 | $0.54 | 26.01 |
| 2009-12-31 | 11.56 | $0.49 | 23.60 |
| 2009-09-30 | 10.23 | $0.38 | 26.92 |
| 2009-06-30 | 8.88 | $0.39 | 22.76 |
| 2009-03-31 | 5.91 | $0.44 | 13.42 |
| 2008-12-31 | 3.87 | $0.39 | 9.93 |
| 2008-09-30 | 12.78 | $0.48 | 26.63 |
| 2008-06-30 | 12.32 | $0.53 | 23.25 |
| 2008-03-31 | 14.76 | $0.51 | 28.93 |
| 2007-12-31 | 12.75 | $0.60 | 21.25 |
| 2007-09-30 | 8.44 | $0.74 | 11.40 |
| 2007-06-30 | 8.64 | $0.61 | 14.16 |
| 2007-03-31 | 10.09 | $0.52 | 19.40 |
| 2006-12-31 | 7.20 | $0.46 | 15.65 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Computer and Technology | Scientific Instruments Manufacturing | $5.722B | $3.437B |
| Bruker Corp designs & manufactures proprietary life science & materials research systems & associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology & in-vitro diagnostics. BSI Life Science reports under two groups: Bruker BioSpin Group & Bruker CALID Group. The Bruker BioSpin comprises the Bruker Magnetic Resonance & Preclinical Imaging divisions, which designs, manufactures & distributes enabling life science tools based on the magnetic resonance technology. The Bruker CALID comprises the Bruker Daltonics & primarily designs, manufactures & distributes life-science mass spectrometry instruments that can be integrated with other sample preparation or chromatography instruments. BSI Nano designs, manufactures & distributes advanced X-ray instruments to determine the characteristics of matter & the three-dimensional structure of molecules. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kewaunee Scientific (KEQU) | United States | $0.100B | 8.24 |
| Harvard Bioscience (HBIO) | United States | $0.019B | 0.00 |